{
    "2018-05-02": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Stagnant Revenues Continue to Hamper the Growth of Pfizer Inc.",
                "features": {
                    "keywords": [
                        "stagnant revenues",
                        "growth hamper",
                        "Pfizer"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Comparing BMY’s and LLY’s Valuation",
                "features": {
                    "keywords": [
                        "BMY",
                        "LLY",
                        "valuation"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "These Pharma Stocks Offer the Most Upside Potential",
                "features": {
                    "keywords": [
                        "pharma stocks",
                        "upside potential"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Humalog and Basaglar: Major Growth Drivers for Eli Lilly in 2018",
                "features": {
                    "keywords": [
                        "Humalog",
                        "Basaglar",
                        "growth drivers",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Eli Lilly Could Report Robust Rise in Net Profit Margins in 2018",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "net profit margins",
                        "robust rise"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Eli Lilly Expected to Report a Modest Rise in Revenues in 2018",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "modest rise",
                        "revenues"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Analyst Recommendations for Eli Lilly after 1Q18 Earnings",
                "features": {
                    "keywords": [
                        "analyst recommendations",
                        "Eli Lilly",
                        "1Q18 earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}